Literature DB >> 11427546

Genetic diversity and biochemical characteristics of Trichosporon asahii isolated from clinical specimens, houses of patients with summer-type-hypersensitivity pneumonitis, and environmental materials.

T Sugita1, T Ichikawa, M Matsukura, M Sueda, M Takashima, R Ikeda, A Nishikawa, T Shinoda.   

Abstract

Trichosporon asahii, which is distributed in the environment, is the major causative agent of the opportunistic infection trichosporonosis, and it also causes summer-type hypersensitivity pneumonitis (SHP). Random amplification of polymorphic DNA analysis was used to determine the intraspecies diversity of 39 T. asahii isolates from clinical specimens, SHP patients' houses, and environmental materials. The three primers used revealed 46 polymorphic bands. A phenogram was generated by the unweighted pair-group method with arithmetic mean. Clinical isolates formed a cluster, characterized by a 90% matching coefficient, but they did not cluster with strains isolated from SHP patients' houses or environmental sources. In addition, the biochemical characteristics of 86 strains from three sources were examined with 31 compounds using an ID32C kit, and a phenogram was constructed. The phenogram consisted of three major clusters. Cluster I included most of the clinical SHP isolates, and cluster II included most of the environmental isolates. Cluster III contained only one strain. A remarkable difference was found in the abilities of the strains belonging to clusters I and II to utilize six compounds. These results suggest that the genetic diversity and biochemical characteristics of T. asahii seem to be related to the source of the isolate. We also found a specific DNA fragment for the clinical isolates and strains isolated from SHP patients' houses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427546      PMCID: PMC88162          DOI: 10.1128/JCM.39.7.2405-2411.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification.

Authors:  T Sugita; A Nishikawa; R Ikeda; T Shinoda
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.

Authors:  C Pujol; S Joly; S R Lockhart; S Noel; M Tibayrenc; D R Soll
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Isolation of Trichosporon asahii from environmental materials.

Authors:  T Sugita; A Nishikawa; T Ichikawa; R Ikeda; T Shinoda
Journal:  Med Mycol       Date:  2000-02       Impact factor: 4.076

4.  Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locus.

Authors:  F Dalle; N Franco; J Lopez; O Vagner; D Caillot; P Chavanet; B Cuisenier; S Aho; S Lizard; A Bonnin
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3.

Authors:  F Marco; S R Lockhart; M A Pfaller; C Pujol; M S Rangel-Frausto; T Wiblin; H M Blumberg; J E Edwards; W Jarvis; L Saiman; J E Patterson; M G Rinaldi; R P Wenzel; D R Soll
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

6.  Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods.

Authors:  K V Clemons; F Feroze; K Holmberg; D A Stevens
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

7.  Clonal and spontaneous origins of fluconazole resistance in Candida albicans.

Authors:  J Xu; A R Ramos; R Vilgalys; T G Mitchell
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Genetic multilocus studies of different strains of Cryptococcus neoformans: taxonomy and genetic structure.

Authors:  S Bertout; F Renaud; D Swinne; M Mallié; J M Bastide
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Identification of Trichosporon asahii by PCR based on sequences of the internal transcribed spacer regions.

Authors:  T Sugita; A Nishikawa; T Shinoda
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity.

Authors:  C A Lyman; S J Devi; J Nathanson; C E Frasch; P A Pizzo; T J Walsh
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

View more
  11 in total

Review 1.  Multilocus sequence typing: Data analysis in clinical microbiology and public health.

Authors:  Christopher B Sullivan; Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2005-03       Impact factor: 2.695

2.  A joint PCR-based gene-targeting method using electroporation in the pathogenic fungus Trichosporon asahii.

Authors:  Yasuhiko Matsumoto; Tae Nagamachi; Asami Yoshikawa; Tsuyoshi Yamada; Takashi Sugita
Journal:  AMB Express       Date:  2022-07-14       Impact factor: 4.126

3.  Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid.

Authors:  Maria Hernandez-Valladares; Rebecca Wangen; Elise Aasebø; Håkon Reikvam; Frode S Berven; Frode Selheim; Øystein Bruserud
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

4.  Differentiation of the emerging human pathogens Trichosporon asahii and Trichosporon asteroides from other pathogenic yeasts and moulds by using species-specific monoclonal antibodies.

Authors:  Genna E Davies; Christopher R Thornton
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

5.  Redox proteomics changes in the fungal pathogen Trichosporon asahii on arsenic exposure: identification of protein responses to metal-induced oxidative stress in an environmentally-sampled isolate.

Authors:  Sidra Ilyas; Abdul Rehman; Ana Coelho Varela; David Sheehan
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

6.  Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole.

Authors:  Jia Chen; Feng Chen; Ying Wang; Ling-Yi Yang; Miao Miao; Yue Han; De-Pei Wu
Journal:  Med Mycol Case Rep       Date:  2014-10-19

7.  Successful treatment of breakthrough disseminated Trichosporon asahii fungemia in a patient with acute myeloid leukemia receiving itraconazole prophylaxis.

Authors:  Daiki Karigane; Masatoshi Sakurai; Emiko Matsuyama; Kentaro Ide; Sakiko Yamamoto-Takeuchi; Toyoko Inazumi; Sumiko Kohashi
Journal:  Med Mycol Case Rep       Date:  2017-11-28

8.  A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP.

Authors:  Yasuhiko Matsumoto; Hideki Yamazaki; Yusuke Yamasaki; Yuki Tateyama; Tsuyoshi Yamada; Takashi Sugita
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

9.  Genetic diversity and antifungal susceptibility testing of Trichosporon asahii isolated of Intensive Care Units patients.

Authors:  Rosana Bellan de Oliveira Silva; Ana Marisa Fusco-Almeida; Marcelo Teruyuki Matsumoto; Lilian Cristiane Baeza; Tatiane Benaducci; Maria José Soares Mendes-Giannini
Journal:  Braz J Microbiol       Date:  2008-09-01       Impact factor: 2.476

10.  Development of an efficient gene-targeting system for elucidating infection mechanisms of the fungal pathogen Trichosporon asahii.

Authors:  Yasuhiko Matsumoto; Tae Nagamachi; Asami Yoshikawa; Hideki Yamazaki; Yusuke Yamasaki; Tsuyoshi Yamada; Takashi Sugita
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.